Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect

Jill M. Williams, Douglas M. Ziedonis, Francisca Abanyie, Marc L. Steinberg, Jonathan Foulds, Neal L. Benowitz

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Fingerprint

Dive into the research topics of 'Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect'. Together they form a unique fingerprint.

Nursing and Health Professions

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases